Prisys Biotechnologies
Biotechnology ResearchView the employees at
Prisys Biotechnologies-
Viola Zhang Pharmacologist, Study Director at Prisys Biotechnologies
-
Shanghai, Shanghai, China
-
Top 10%
Kevin Zhang Chief Scientific Officer at Prisys Biotechnologies-
Shanghai, China
-
Top 10%
Wei Liu Associate Director at Prisys Biotechnologies-
Shanghai, China
-
Rising Star
Yijing Wei BD specialist-Prisys Biotechnologies(Nonhuman Primate/In vivo Pharmacology/CRO))-
Shanghai, China
-
Rising Star
Overview
Prisys is a CRO company, pioneering in non-human primate (NHP) pharmacology, to provide peri-clinical studies of new drug development. Prisys integrated its proprietary modeling expertise and rich pharmacology experience with top-equipped local clinical hospitals, enabling global pharms to access the latest innovational approaches for more translatable and more efficient advancement of new therapeutics. With the huge unmet needs for more clinical relevance and predictions of human-target specific novel therapeutic strategies, Prisys has been continually developing different NHP models covering the following key disease areas: • Inflammatory • Autoimmune • Cardiovascular • Cerebrovascular • Hematology • Kidney • Liver • Lung • Ophthalmology • OB-GYN • Oncology Contact us at : info@prisysbiotech.com For more information please visit Website: www.prisysbiotech.com
-